Objective: To determine the role of bone marrow biopsy (BMBX), performed in association with comprehensive blood and imaging tests, in the evaluation of patients with fever of unknown origin (FUO).
Patients and Methods:We reviewed the medical records of 475 hospitalized patients who underwent BMBX in our medical center from January 1, 2005, to April 30, 2010. We identified 75 patients who fulfilled the accepted classic Petersdorf criteria for FUO. All patients underwent in-hospital investigation for fever, including chest and abdominal computed tomography. Results: In 20 patients (26.7%), BMBX established the final diagnosis. Sixteen patients had hematologic disorders, including 8 patients with non-Hodgkin lymphoma, 2 with acute leukemia, 1 with multiple myeloma, 1 with myelodysplastic syndrome, and 4 with myeloproliferative disorders. The remaining patients with diagnostic BMBX specimens had solid tumors (2 patients), granulomatous disease (1 patient), and hemophagocytic syndrome (1 patient). Multivariate analysis revealed the following as the significant positive predictive parameters for a diagnostic BMBX specimen: male sex (odds ratio [OR] E ven in the current era of widespread use of advanced medical technologies, the investigation of fever of unknown origin (FUO) still remains a major diagnostic challenge for many physicians. Not much has changed in the past 5 decades since Petersdorf and Beeson 1 established the working definition of FUO, namely, an illness of more than 3 weeks' duration, accompanied by a temperature greater than 38.3°C on several occasions, the cause of which was uncertain after 1 week of inhospital investigation.Diagnosing FUO is difficult for both patients and physicians because the spectrum of diseases causing FUO is wide and includes numerous conditions, entailing many noninvasive and invasive diagnostic procedures. [2][3][4][5][6][7][8][9][10] The use of bone marrow biopsy (BMBX) has been traditionally considered a second-line procedure to achieve diagnosis because of the invasive nature of the procedure. Nevertheless, BMBX was shown in earlier studies to be a useful but limited adjunct to the clinical work-up of FUO. These reported studies were mostly undertaken in patients with human immunodeficiency virus (HIV) infection 5,9 and in those suspected of having mycobacterial disease. 11 A recent study conducted in hospitalized patients identified anemia and thrombocytopenia as positive predictors for a diagnostic BMBX specimen. 12 However, the exact role for BMBX in the evaluation of patients who have already undergone extensive blood tests and computed tomography (CT) of the chest and abdomen has not yet been defined.We present the diagnostic yield of BMBX in the evaluation of 75 patients with prolonged fever who were admitted to a tertiary medical center. Our results identify simple clinical and laboratory parameters as predictive indicators that increase the diagnostic yield of BMBX in the modern investigation of FUO. We believe that implementing these predictive laborator...